US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist
  • 1.730
  • +0.040+2.37%
Close Nov 29 13:00 ET
  • 1.730
  • 0.0000.00%
Post 13:02 ET
83.49MMarket Cap-1406P/E (TTM)

Ikena Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-41.35%9.16M
-87.91%659K
-81.49%1.19M
424.61%2M
57.00%5.31M
-49.59%15.62M
-73.04%5.45M
Operating revenue
--0
--0
--0
-41.35%9.16M
-87.91%659K
-81.49%1.19M
424.61%2M
57.00%5.31M
-49.59%15.62M
-73.04%5.45M
Cost of revenue
Gross profit
Operating expense
-43.95%11.6M
-26.12%15.14M
-24.89%15.64M
-2.25%84.58M
9.74%22.57M
-14.79%20.69M
-3.93%20.49M
2.37%20.83M
32.86%86.52M
18.01%20.56M
Selling and administrative expenses
-20.83%4.78M
-0.26%5.31M
13.70%6M
12.27%24.93M
68.39%8.29M
11.16%6.03M
-8.95%5.32M
-12.11%5.28M
23.24%22.2M
-3.18%4.93M
-General and administrative expense
-20.83%4.78M
-0.26%5.31M
13.70%6M
12.27%24.93M
68.39%8.29M
11.16%6.03M
-8.95%5.32M
-12.11%5.28M
23.24%22.2M
-3.18%4.93M
Research and development costs
-53.47%6.82M
-35.20%9.83M
-37.98%9.65M
-7.26%59.65M
-8.73%14.27M
-22.26%14.65M
-2.04%15.17M
8.43%15.55M
36.54%64.32M
26.75%15.64M
Operating profit
40.55%-11.6M
18.12%-15.14M
-0.83%-15.64M
-6.36%-75.42M
-44.95%-21.91M
-9.10%-19.5M
11.75%-18.49M
8.53%-15.52M
-107.70%-70.9M
-641.33%-15.11M
Net non-operating interest income expense
Other net income (expense)
-36.53%1.37M
7.05%1.47M
-136.65%-475K
231.42%7.09M
121.93%2.26M
301.49%2.16M
198.91%1.38M
2,744.90%1.3M
2.14M
1.02M
Gain on sale of security
-18.09%1.77M
39.03%1.92M
63.12%2.11M
230.90%7.11M
123.96%2.27M
293.09%2.16M
200.22%1.38M
--1.3M
--2.15M
--1.01M
Special income (charges)
---812K
---683K
---2.58M
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--812K
--683K
--2.58M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
20,700.00%412K
4,016.67%235K
---7K
-120.00%-22K
-566.67%-14K
83.33%-2K
---6K
----
---10K
--3K
Income before tax
41.05%-10.22M
20.14%-13.67M
-13.36%-16.12M
0.64%-68.33M
-39.40%-19.65M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Income tax
10K
62K
27K
-162K
-162K
0
0
0
0
Net income
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Net income continuous Operations
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Minority interest income
Net income attributable to the parent company
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.99%-10.23M
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
Basic earnings per share
47.50%-0.21
36.36%-0.28
15.38%-0.33
14.21%-1.63
-2.56%-0.4
16.67%-0.4
22.81%-0.44
17.02%-0.39
-55.74%-1.9
-262.50%-0.39
Diluted earnings per share
47.50%-0.21
36.36%-0.28
15.38%-0.33
14.21%-1.63
-2.56%-0.4
16.67%-0.4
22.81%-0.44
17.02%-0.39
-55.74%-1.9
-262.50%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-41.35%9.16M-87.91%659K-81.49%1.19M424.61%2M57.00%5.31M-49.59%15.62M-73.04%5.45M
Operating revenue --0--0--0-41.35%9.16M-87.91%659K-81.49%1.19M424.61%2M57.00%5.31M-49.59%15.62M-73.04%5.45M
Cost of revenue
Gross profit
Operating expense -43.95%11.6M-26.12%15.14M-24.89%15.64M-2.25%84.58M9.74%22.57M-14.79%20.69M-3.93%20.49M2.37%20.83M32.86%86.52M18.01%20.56M
Selling and administrative expenses -20.83%4.78M-0.26%5.31M13.70%6M12.27%24.93M68.39%8.29M11.16%6.03M-8.95%5.32M-12.11%5.28M23.24%22.2M-3.18%4.93M
-General and administrative expense -20.83%4.78M-0.26%5.31M13.70%6M12.27%24.93M68.39%8.29M11.16%6.03M-8.95%5.32M-12.11%5.28M23.24%22.2M-3.18%4.93M
Research and development costs -53.47%6.82M-35.20%9.83M-37.98%9.65M-7.26%59.65M-8.73%14.27M-22.26%14.65M-2.04%15.17M8.43%15.55M36.54%64.32M26.75%15.64M
Operating profit 40.55%-11.6M18.12%-15.14M-0.83%-15.64M-6.36%-75.42M-44.95%-21.91M-9.10%-19.5M11.75%-18.49M8.53%-15.52M-107.70%-70.9M-641.33%-15.11M
Net non-operating interest income expense
Other net income (expense) -36.53%1.37M7.05%1.47M-136.65%-475K231.42%7.09M121.93%2.26M301.49%2.16M198.91%1.38M2,744.90%1.3M2.14M1.02M
Gain on sale of security -18.09%1.77M39.03%1.92M63.12%2.11M230.90%7.11M123.96%2.27M293.09%2.16M200.22%1.38M--1.3M--2.15M--1.01M
Special income (charges) ---812K---683K---2.58M----------0--0--0--------
-Less：Restructuring and merger&acquisition --812K--683K--2.58M----------0--0--0--------
Other non- operating income (expenses) 20,700.00%412K4,016.67%235K---7K-120.00%-22K-566.67%-14K83.33%-2K---6K-------10K--3K
Income before tax 41.05%-10.22M20.14%-13.67M-13.36%-16.12M0.64%-68.33M-39.40%-19.65M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Income tax 10K62K27K-162K-162K0000
Net income 40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Net income continuous Operations 40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Minority interest income
Net income attributable to the parent company 40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.99%-10.23M19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M
Basic earnings per share 47.50%-0.2136.36%-0.2815.38%-0.3314.21%-1.63-2.56%-0.416.67%-0.422.81%-0.4417.02%-0.39-55.74%-1.9-262.50%-0.39
Diluted earnings per share 47.50%-0.2136.36%-0.2815.38%-0.3314.21%-1.63-2.56%-0.416.67%-0.422.81%-0.4417.02%-0.39-55.74%-1.9-262.50%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data